Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Azacitidine Neapolis


Contraindicated
Reproductive toxicity in animals

Contraindicated
Azacitidine Neapolis :
Type Medicine Authorised
Originator Vidaza
Agent MedisPharm
Distributor MedisPharm
Laboratory Neapolis Pharma
Responsible Party Neapolis Pharma
Origin Tunisia
Manufacturer Neapolis Pharma
Manufacturing Type G
Origin Tunisia
ATC L01BC07

Your comment will appear shortly after approval

Azacitidine Neapolis :

Revision Date : 17/02/2015


Effect Frequency
Abdominal pain Very Common
Acute febrile neutrophilic dermatosis (Sweet's syndrome) Uncommon
Alopecia Common
Anaemia Very Common
Anaphylactoid reactions Not known
Anorexia Very Common
Anxiety Common
Arthralgia (Pain joint) (Joint ache) Very Common
Bleeding Not known
Bone marrow failure Common
Cardiac disorder Not known
Cellulitis Common
Cerebral haemorrhage Not known
Chest pain Very Common
Coma hepatic Uncommon
Confusional state Common
Conjunctival haemorrhage Common
Constipation Very Common
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Dyspepsia Common
Dyspnoea (dyspnea) Very Common
Dyspnoea exertional Common
Ecchymosis Very Common
Erythema Common
Eye haemorrhage Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Gastroduodenal haemorrhage Common
Gingival bleeding (Gingival hemorrhage) Common
Haematoma Common
Haematuria (Hematuria) Common
Haemorrhage intracranial Common
Haemorrhoidal haemorrhage Common
Headache Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Uncommon
Herpes simplex Common
Hypersensitivity reactions Uncommon
Hypertension Common
Hypokalaemia Common
Hypotension Common
Injection site bruising Common
Injection site discolouration Common
Injection site erythema Very Common
Injection site haematoma Common
Injection site haemorrhage Common
Injection site induration Common
Injection site inflammation Common
Injection site necrosis Rare
Injection site nodule Common
Injection site pain Very Common
Injection site pruritus Common
Injection site rash Common
Injection site reaction Very Common
Insomnia Common
Interstitial pneumonitis Rare
Lethargy Common
Leucopenia (Leukopenia) Very Common
Malaise Common
Musculoskeletal pain Common
Myalgia Common
Nasopharyngitis Very Common
Nausea Very Common
Necrotizing fasciitis Not known
Neutropenia Very Common
Neutropenic sepsis Common
Pancytopenia Common
Petechiae Very Common
Pharyngitis Common
Pharyngolaryngeal pain Common
Pneumonia Very Common
Pruritus Very Common
Purpura Common
Pyrexia Very Common
Rash macular Common
Renal failure Common
Renal tubular acidosis Uncommon
Rhinitis Common
Serum creatinine increased Common
Sinusitis Common
Skin lesion Not known
Skin rash Very Common
Stomatitis Common
Thrombocytopenia (Thrombopenia) Very Common
Tumour lysis syndrome Rare
Upper respiratory tract infection Common
Urinary tract infection Common
Vomiting Very Common
Weight decreased (Weight loss) Common

Different Units By MoH Code

Revision Date : 01/02/2019

Azacitidine Neapolis  MoH 10154 :
Form Powder for suspension for injection
Packaging Bottle
Package Size 1x4ml
Strength 100mg
Public Price 9401574,85 L.L.
Stratum C
NSSF ✘
Quarantine ✘
Reg. Number 99219/1
Submission date 17/06/2019
Registration Year 19/09/2019
Pending Year 27/06/2019
Pending Reason Postponement (mini-committee)


Price Comparison

● Country: Lebanon
● Form: Powder for suspension for injection
● Package Size: 1x4ml
● Public Price: 9401574.85 LBP ( 9,401,574.85 LBP )
● Pack size unit used: 1
● Cost/Unit: 9401574,85 LBP ( 9,401,574.00 LBP )
● Pricing Date: 10/11/2025

● Country: Germany
● Package Size: 1
● Medica Comments: Not available in the country of origin
● Pricing Date: 20/10/2020
● Type: Medicine not available

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info